Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bluebird bio Inc (NASDAQ: BLUE) closed the day trading at $7.79 up 1.70% from the previous closing price of $7.66. In other words, the price has increased by $1.70 from its previous closing price. On the day, 0.26 million shares were traded. BLUE stock price reached its highest trading level at $8.24 during the session, while it also had its lowest trading level at $7.5704.
Ratios:
For a better understanding of BLUE, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.33 and its Current Ratio is at 0.51.
On November 15, 2024, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $3 to $0.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 10 ’24 when Obenshain Andrew sold 971 shares for $0.42 per share. The transaction valued at 405 led to the insider holds 374,247 shares of the business.
Colvin Richard A sold 2,824 shares of BLUE for $1,178 on Dec 10 ’24. The Chief Medical Officer now owns 165,544 shares after completing the transaction at $0.42 per share. On Dec 10 ’24, another insider, Colvin Richard A, who serves as the Officer of the company, bought 2,824 shares for $0.45 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLUE now has a Market Capitalization of 75736096 and an Enterprise Value of 321886080. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.46. Its current Enterprise Value per Revenue stands at 5.863 whereas that against EBITDA is -1.065.
Stock Price History:
Over the past 52 weeks, BLUE has reached a high of $38.40, while it has fallen to a 52-week low of $5.80. The 50-Day Moving Average of the stock is -8.30%, while the 200-Day Moving Average is calculated to be -51.42%.
Shares Statistics:
Over the past 3-months, BLUE traded about 420.62K shares per day on average, while over the past 10 days, BLUE traded about 638173 shares per day. A total of 9.70M shares are outstanding, with a floating share count of 9.64M. Insiders hold about 0.88% of the company’s shares, while institutions hold 34.11% stake in the company. Shares short for BLUE as of 1730332800 were 47705814 with a Short Ratio of 5.89, compared to 1727654400 on 48991273. Therefore, it implies a Short% of Shares Outstanding of 47705814 and a Short% of Float of 26.66.
